Cowen & Co. Initiates Coverage On Aerovate Therapeutics with Outperform Rating

Cowen & Co. analyst Joseph Thome initiates coverage on Aerovate Therapeutics (NASDAQ:AVTE) with a Outperform rating.

Cowen & Co. analyst Joseph Thome initiates coverage on Aerovate Therapeutics (NASDAQ:AVTE) with a Outperform rating.

Total
0
Shares
Related Posts